Medicare to limit coverage for Aduhelm, an Alzheimer's drug with questionable benefits that triggered a jump in premiums
WASHINGTON (AP) - Medicare to limit coverage for Aduhelm, an Alzheimer's drug with questionable benefits that triggered a jump in premiums. |!| Pocatello